脉络舒通丸联合阿托伐他汀对冠心病PCI 术患者血脂, 炎症因子及术后再狭窄的影响.
胡文星， 赵春容， 周玲娟， 刘娟珠… - Progress in Modern …, 2022 - search.ebscohost.com
摘要目的: 探讨脉络舒通丸联合阿托伐他汀对冠心病经皮冠状动脉介入(PCI) 术患者血脂,
炎症因子及术后再狭窄的影响. 方法: 选择2018 年5 月~ 2020 年2 月期间我院接收的冠心病PCI …
炎症因子及术后再狭窄的影响. 方法: 选择2018 年5 月~ 2020 年2 月期间我院接收的冠心病PCI …
Antithrombotic therapy with ticagrelor in atrial fibrillation subjects after percutaneous coronary intervention
W Lu, Y Wang, L Chen, Y Li, R Zhang… - Frontiers in …, 2021 - frontiersin.org
Background: Warfarin, along with aspirin and clopidogrel, has long been recommended for
patients with atrial fibrillation (AF) who are undergoing percutaneous coronary intervention …
patients with atrial fibrillation (AF) who are undergoing percutaneous coronary intervention …
Real-world analysis of a Biolimus A9 polymer-free drug-coated stent with very short dual antiplatelet therapy in patients at high bleeding risk
C Grigorios, C Georgios, F Hannes, M Paul… - Herz, 2021 - search.proquest.com
Background Patients at high risk of bleeding requiring percutaneous coronary intervention
(PCI) need careful evaluation of both their thrombotic and their bleeding risks. In these …
(PCI) need careful evaluation of both their thrombotic and their bleeding risks. In these …
AUDITS: Mnemonical Approach for Atrial Fibrillation With Coronary Artery Disease
MT El Hussein, J Habib - The Journal for Nurse Practitioners, 2021 - Elsevier
Managing anticoagulation therapy in patients with acute coronary syndrome and atrial
fibrillation requires effective use of risk stratification scores to optimize treatment options …
fibrillation requires effective use of risk stratification scores to optimize treatment options …
[HTML][HTML] Safety and efficacy of percutaneous coronary intervention combined with catheter ablation in a single procedure for patients with coronary artery disease …
L Chen, T Liang, H Gao, H Zhang - 2022 - europepmc.org
Background: Coronary artery disease (CAD) always co-exists with atrial fibrillation (AF). A
new delivery of cardiac interventions for patients is needed during or even after the 2019 …
new delivery of cardiac interventions for patients is needed during or even after the 2019 …
[PDF][PDF] The impact of sex and age in the treatment of atrial fibrillation
A Bah - 2022 - erepo.uef.fi
Atrial fibrillation (AF) causes a five-fold increase in the risk of stroke and is responsible for 10
to 15% of ischemic strokes. Ageing, female sex and several comorbidities increase the risk …
to 15% of ischemic strokes. Ageing, female sex and several comorbidities increase the risk …
Uso de triple terapia antitrombótica en pacientes con antecedente de evento cardiovascular mayor
J Arguedas Rojas - kerwa.ucr.ac.cr
La utilización de triple terapia antitrombótica, al combinar un anticoagulante oral directo y
doble antiagregación plaquetaria, ha ganado popularidad durante la última década y ha …
doble antiagregación plaquetaria, ha ganado popularidad durante la última década y ha …
Fibrilación auricular y cardiopatía isquémica: más allá de la prevención del ictus
EA Ezquerra, RA Bermejo, LJA Perez… - Revista Española de …, 2020 - Elsevier
El objetivo principal en el abordaje del paciente con fibrilación auricular es la reducción del
riesgo de ictus mediante el tratamiento antitrombótico adecuado. Sin embargo, a pesar de …
riesgo de ictus mediante el tratamiento antitrombótico adecuado. Sin embargo, a pesar de …
Untersuchung eines polymerfreien medikamentenbeschichteten Biolimus-A9-Stents mit sehr kurzer dualer Plättchenhemmung unter Realbedingungen bei Patienten …
G Chatzantonis, G Chatzantonis, H Findeisen, M Paul… - Herz, 2021 - Springer
Background Patients at high risk of bleeding requiring percutaneous coronary intervention
(PCI) need careful evaluation of both their thrombotic and their bleeding risks. In these …
(PCI) need careful evaluation of both their thrombotic and their bleeding risks. In these …